Madeline Choi
Directeur Général chez DNAGO.Ai
Fortune : 1 M $ au 31/05/2024
Profil
Madeline Choi is currently the Chief Executive Officer at DNAGO.Ai.
Prior to this, she worked as a Secretary at Hi-Great Group Holding Co. from 2020 to 2022.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2022 | 1 000 000 ( 1,06% ) | 1 M $ | 31/05/2024 |
Postes actifs de Madeline Choi
| Sociétés | Poste | Début |
|---|---|---|
DNAGO.Ai
 DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Directeur Général | - |
Anciens postes connus de Madeline Choi
| Sociétés | Poste | Fin |
|---|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Secrétaire Général | 22/09/2022 |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HI-GREAT GROUP HOLDING COMPANY | Distribution Services |
| Entreprise privées | 1 |
|---|---|
DNAGO.Ai
DNAGO.Ai Medical/Nursing ServicesHealth Services Part of Oncologix Tech, Inc., DNAGO.Ai is a company that specializes in cell banking technology, specifically in dermal papilla cells. The company is based in Irvine, CA. The company also conducts research in other areas and have a research institute. The CEO of the company is Madeline Choi. DNAGO.Ai was acquired by Oncologix Tech, Inc. on June 30, 2022. | Health Services |
